Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Lab Invest ; 100(8): 1124-1136, 2020 08.
Article in English | MEDLINE | ID: mdl-32341516

ABSTRACT

Brightfield microscopy is the preferred method of pathologists for diagnosing solid tumors, utilizing common staining techniques such as hematoxylin and eosin staining and immunohistochemistry (IHC). However, as our understanding of the complex tumor microenvironment grows, there is increasing demand for multiplexed biomarker detection. Currently, multiplexed IHC assays are almost exclusively based on immunofluorescence because brightfield techniques are limited by the broad spectral absorption of chromogens and a reliance on conventional 3-channel color cameras. In this work, we overcome these limitations by combining new chromogens possessing narrow absorbance bands with matched illumination channels and monochrome imaging. Multiplex IHC was performed using four or five covalently deposited chromogens and hematoxylin nuclear stain to preserve morphological context and detail. Brightfield illumination was provided with a tungsten lamp/filter wheel combination or filtered light emitting diodes to provide up to 12 illumination wavelengths. In addition, an automated rapid imaging system was developed, using a synchronized 12-LED illuminator, that could capture images at all wavelengths in under 1 s. In one example, a four-biomarker multiplex assay was designed and used to distinguish regions of adenocarcinoma and squamous cell carcinoma in non-small cell lung cancer. The technology was also validated with a five-biomarker assay in prostate cancer. Spectrally unmixed images of each biomarker demonstrated concordant expression patterns with DAB single stain on serial sections, indicating faithful identification of each biomarker. In each assay, all chromogens were well resolved by spectral unmixing to remove spectral crosstalk. While further characterization and refinement of the assay, and improvements in automation and user interface are necessary for pathologist acceptance, this approach to multiplex IHC and multispectral imaging has the potential to accelerate adoption of multiplexing by combining the medical value of high-order multiplexing with the speed, pathologist familiarity, and broadly established clinical utility of brightfield microscopy.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Non-Small-Cell Lung/metabolism , Diagnostic Imaging/methods , Immunohistochemistry/methods , Lung Neoplasms/metabolism , Staining and Labeling/methods , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Carcinoma, Non-Small-Cell Lung/diagnostic imaging , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Squamous Cell/diagnostic imaging , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Fluorescent Antibody Technique/methods , Humans , Lung Neoplasms/diagnostic imaging , Lung Neoplasms/pathology , Microscopy, Fluorescence/methods , Reproducibility of Results , Sensitivity and Specificity , Tumor Microenvironment
2.
Ann Diagn Pathol ; 45: 151454, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31923744

ABSTRACT

Lung cancer is the most common cancer worldwide and has the highest mortality rate. Carcinomas comprise 95% of all lung malignancies, the vast majority of which are non-small cell lung carcinomas (NSCLC). Increasingly, the diagnosis of lung cancer is established by examination of small tissue specimens obtained by minimally invasive techniques. It is critical to employ these tissues at maximum efficiency in order to render an accurate pathologic diagnosis and to perform theranostic studies, either genomic or by immunohistochemistry, to demonstrate genetic mutations that make patients eligible for molecularly targeted agents. Currently Thyroid Transcription Factor-1 (TTF-1) and Napsin A are the most commonly used immunohistochemical (IHC) stains to identify primary lung adenocarcinoma, and p40 and cytokeratin 5/6 (CK5/6) are used for squamous cell carcinoma. IHC stains for these markers, are performed either individually (IHC brown staining) or in combination as dual immunostains (i.e. TTF-1 + Napsin A and p40 + CK5/6, utilizing brown and red chromogens). Here we present a novel, truly multiplex immunohistochemical approach that combines staining with the above four antibodies on a single tissue section utilizing four different chromogens to accurately diagnose primary lung adenocarcinomas, squamous cell carcinomas, and combined adenosquamous carcinomas of the lung. Each marker is represented by a distinct color that can be read by a pathologist, using standard, bright field microscopy. We evaluated the ability of pathologists to differentiate NSCLCs using the multiplexed assay as compared to standard, single marker per slide diaminobenzidine (DAB)-based IHC. All cases in a cohort of 264 NSCLCs showed concordance of information (including positivity of stain, intensity of stain and coverage) between single IHC stains and the multiplex assay. This new multiplex IHC offers the capability to accurately diagnose and sub-classify primary lung NSCLCs, while conserving precious tissue for additional testing.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinoma, Non-Small-Cell Lung/diagnosis , Carcinoma, Non-Small-Cell Lung/metabolism , Immunohistochemistry/methods , Lung Neoplasms/diagnosis , Adenocarcinoma/diagnosis , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Aspartic Acid Endopeptidases/genetics , Carcinoma, Adenosquamous/diagnosis , Carcinoma, Adenosquamous/metabolism , Carcinoma, Adenosquamous/pathology , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Non-Small-Cell Lung/surgery , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Chromogenic Compounds , Diagnosis, Differential , Humans , Immunodominant Epitopes/metabolism , Keratin-5/metabolism , Keratin-6/metabolism , Lung Neoplasms/pathology , Neoplasm Staging , Peptide Fragments/metabolism , Thyroid Nuclear Factor 1/genetics
3.
Lab Invest ; 97(1): 104-113, 2017 01.
Article in English | MEDLINE | ID: mdl-27869794

ABSTRACT

Multiplexed analysis of multiple biomarkers in a tissue sample requires use of reporter dyes with specific spectral properties that enable discrimination of signals. Conventional chromogens with broad absorbance spectra, widely used in immunohistochemistry (IHC), offer limited utility for multiplexed detection. Many dyes with narrow absorbance spectra, eg rhodamines, fluoresceins, and cyanines, potentially useful for multiplexed detection are well-characterized; however, generation of a chromogenic reagent useful for IHC analysis has not been demonstrated. Studies reported herein demonstrate utility of tyramine-chemistry for synthesis of a wide variety of new chromogenic dye conjugates useful for multiplexed in situ analysis using conventional light microscopes. The dyes, useful individually or in blends to generate new colors, provide signal sensitivity and dynamic range similar to conventional DAB chromogen, while enabling analysis of co-localized biomarkers. It is anticipated that this new paradigm will enable generation of a wide variety of new chromogens, useful for both research and clinical biomarker analysis that will benefit clinicians and patients.


Subject(s)
Biomarkers/analysis , Chromogenic Compounds/chemistry , Coloring Agents/chemistry , Immunohistochemistry/methods , In Situ Hybridization/methods , 3,3'-Diaminobenzidine/chemistry , Biomarkers/chemistry , Chromogenic Compounds/chemical synthesis , Coloring Agents/chemical synthesis , Humans , Models, Chemical , Molecular Structure , Reproducibility of Results , Tyramine/chemistry
4.
Nat Cell Biol ; 13(4): 453-60, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21394080

ABSTRACT

mTOR (mammalian target of rapamycin) signalling and macroautophagy (henceforth autophagy) regulate numerous pathological and physiological processes, including cellular responses to altered nutrient levels. However, the mechanisms regulating mTOR and autophagy remain incompletely understood. Lysosomes are dynamic intracellular organelles intimately involved both in the activation of mTOR complex 1 (mTORC1) signalling and in degrading autophagic substrates. Here we report that lysosomal positioning coordinates anabolic and catabolic responses with changes in nutrient availability by orchestrating early plasma-membrane signalling events, mTORC1 signalling and autophagy. Activation of mTORC1 by nutrients correlates with its presence on peripheral lysosomes that are physically close to the upstream signalling modules, whereas starvation causes perinuclear clustering of lysosomes, driven by changes in intracellular pH. Lysosomal positioning regulates mTORC1 signalling, which in turn influences autophagosome formation. Lysosome positioning also influences autophagosome-lysosome fusion rates, and thus controls autophagic flux by acting at both the initiation and termination stages of the process. Our findings provide a physiological role for the dynamic state of lysosomal positioning in cells as a coordinator of mTORC1 signalling with autophagic flux.


Subject(s)
Food , Lysosomes/metabolism , Lysosomes/ultrastructure , Proteins/metabolism , Autophagy/physiology , HeLa Cells , Humans , Mechanistic Target of Rapamycin Complex 1 , Multiprotein Complexes , Proteins/genetics , Signal Transduction/physiology , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/metabolism
5.
Immunity ; 32(3): 329-41, 2010 Mar 26.
Article in English | MEDLINE | ID: mdl-20206555

ABSTRACT

Autophagy allows cells to self-digest portions of their own cytoplasm for a multitude of physiological purposes, including innate and adaptive immunity functions. In one of its innate immunity manifestations, autophagy, is known to contribute to the killing of intracellular microbes, including Mycobacterium tuberculosis, although the molecular mechanisms have been unclear. Here, we delineated sequential steps of the autophagic pathway necessary to control intracellular M. tuberculosis and found that in addition to autophagy initiation and maturation, an accessory autophagy-targeting molecule p62 (A170 or SQSTM1) was required for mycobactericidal activity. The p62 adaptor protein delivered specific ribosomal and bulk ubiquitinated cytosolic proteins to autolysosomes where they were proteolytically converted into products capable of killing M. tuberculosis. Thus, p62 brings cytosolic proteins to autolysosomes where they are processed from innocuous precursors into neo-antimicrobial peptides, explaining in part the unique bactericidal properties of autophagic organelles.


Subject(s)
Adaptor Proteins, Signal Transducing/immunology , Autophagy , Cytosol/immunology , Heat-Shock Proteins/immunology , Mycobacterium tuberculosis/immunology , Animals , Biological Transport , Cells, Cultured , Cytosol/metabolism , Mice , Mice, Inbred C57BL , Phagosomes/immunology , Phagosomes/metabolism , Protein Binding , Sequestosome-1 Protein , Ubiquitin/metabolism
6.
Vet Immunol Immunopathol ; 128(1-3): 37-43, 2009 Mar 15.
Article in English | MEDLINE | ID: mdl-19026454

ABSTRACT

Autophagy is a major intracellular pathway for the lysosomal degradation of long-lived cytoplasmic macromolecules and damaged or surplus organelles. More recently, autophagy has also been linked with innate and adaptive immune responses against intracellular pathogens, including Mycobacterium tuberculosis, which can survive within macrophages by blocking fusion of the phagosome with lysosomes. Induction of autophagy by the Th1 cytokine IFN-gamma enables infected macrophages to overcome this phagosome maturation block and inhibit the intracellular survival of mycobacteria. Conversely, the Th2 cytokines IL-4 and IL-13 inhibit autophagy in murine and human macrophages. We discuss how differential modulation of autophagy by Th1 and Th2 cytokines may represent an important feature of the host response to mycobacteria.


Subject(s)
Autophagy/physiology , Cytokines/physiology , Macrophages/microbiology , Macrophages/physiology , Mycobacterium tuberculosis/physiology , Animals , Humans , Immunity, Innate , Interferon-gamma/physiology , Interleukin-13/physiology , Interleukin-4/physiology , Phagosomes , Th1 Cells/immunology , Th2 Cells/immunology
7.
Nat Cell Biol ; 10(7): 776-87, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18552835

ABSTRACT

Autophagic and endocytic pathways are tightly regulated membrane rearrangement processes that are crucial for homeostasis, development and disease. Autophagic cargo is delivered from autophagosomes to lysosomes for degradation through a complex process that topologically resembles endosomal maturation. Here, we report that a Beclin1-binding autophagic tumour suppressor, UVRAG, interacts with the class C Vps complex, a key component of the endosomal fusion machinery. This interaction stimulates Rab7 GTPase activity and autophagosome fusion with late endosomes/lysosomes, thereby enhancing delivery and degradation of autophagic cargo. Furthermore, the UVRAG-class-C-Vps complex accelerates endosome-endosome fusion, resulting in rapid degradation of endocytic cargo. Remarkably, autophagosome/endosome maturation mediated by the UVRAG-class-C-Vps complex is genetically separable from UVRAG-Beclin1-mediated autophagosome formation. This result indicates that UVRAG functions as a multivalent trafficking effector that regulates not only two important steps of autophagy - autophagosome formation and maturation - but also endosomal fusion, which concomitantly promotes transport of autophagic and endocytic cargo to the degradative compartments.


Subject(s)
Autophagy/physiology , Endocytosis/physiology , Multiprotein Complexes/metabolism , Phagosomes/metabolism , Vesicular Transport Proteins/metabolism , Animals , Apoptosis Regulatory Proteins , Beclin-1 , Cell Line , Endosomes/metabolism , Humans , Lysosomes/metabolism , Membrane Fusion/physiology , Membrane Proteins , Mice , Protein Transport/physiology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Tumor Suppressor Proteins , Vesicular Transport Proteins/genetics , rab GTP-Binding Proteins/genetics , rab GTP-Binding Proteins/metabolism
8.
Methods Mol Biol ; 445: 111-7, 2008.
Article in English | MEDLINE | ID: mdl-18425445

ABSTRACT

Autophagy is a cellular homeostasis pathway used to sustain cellular anabolic needs during times of nutrient or energy deprivation. Autophagosomes sequester cytoplasmic constituents, including macromolecules such as long-lived proteins. Upon fusion of autophagosomes with lysosomes, the engulfed cargo is degraded. The proteolysis of longlived proteins by macroautophagy is a standard, specific measure of autophagic degradation and represents an end-point assay for the pathway. The assay is based on a pulse-chase approach, whereby cellular proteins are radiolabeled by an isotopically marked amino acid, the short-lived, rapidly turned over, proteins are allowed to be degraded during a long chase period, and then the remaining, stable radiolabeled proteins are subjected to autophagic degradation. The classical application of this method has been in hepatocytes, but the recent growth of interest in autophagy has necessitated adaptation of this method in nonliver cells. Here we describe a protocol to quantify autophagic degradation of longlived proteins in macrophages. This chapter details the method of analyzing autophagic proteolysis in RAW264.7 mouse macrophages.


Subject(s)
Autophagy/physiology , Macrophages/metabolism , Proteins/metabolism , Animals , Cell Line , Macrophages/cytology
9.
Methods Mol Biol ; 445: 439-49, 2008.
Article in English | MEDLINE | ID: mdl-18425467

ABSTRACT

Tuberculosis is currently the most devastating human bacterial disease, causing millions of deaths annually and infecting an overwhelming percentage of the global population. Its success as a scourge lies in the ability of Mycobacterium tuberculosis to prevent normal phagolysosome biogenesis, essential to the destruction of invading microorganisms, inside macrophages. Recent work has identified host GTPases involved in the block of normal phagolysosome biogenesis during mycobacterial infection and has provided a set of methods, in particular efficient macrophage transfection, which will prove essential in examining the role of host effectors in this process.


Subject(s)
Mycobacterium tuberculosis/growth & development , Phagosomes/metabolism , Animals , Cell Line , Macrophages/cytology , Macrophages/metabolism , Macrophages/microbiology , Models, Biological , rab GTP-Binding Proteins/metabolism , rab GTP-Binding Proteins/physiology
10.
Immunity ; 27(3): 505-17, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17892853

ABSTRACT

Autophagy is a recently recognized immune effector mechanism against intracellular pathogens. The role of autophagy in innate immunity has been well established, but the extent of its regulation by the adaptive immune response is less well understood. The T helper 1 (Th1) cell cytokine IFN-gamma induces autophagy in macrophages to eliminate Mycobacterium tuberculosis. Here, we report that Th2 cytokines affect autophagy in macrophages and their ability to control intracellular M. tuberculosis. IL-4 and IL-13 abrogated autophagy and autophagy-mediated killing of intracellular mycobacteria in murine and human macrophages. Inhibition of starvation-induced autophagy by IL-4 and IL-13 was dependent on Akt signaling, whereas the inhibition of IFN-gamma-induced autophagy was Akt independent and signal transducer and activator of transcription 6 (STAT6) dependent. These findings establish a mechanism through which Th1-Th2 polarization differentially affects the immune control of intracellular pathogens.


Subject(s)
Autophagy/immunology , Interleukin-13/immunology , Interleukin-4/immunology , Macrophages/immunology , Mycobacterium tuberculosis/immunology , Th2 Cells/immunology , Animals , Cell Line , Cytokines , Flow Cytometry , Humans , Immunoblotting , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-13/metabolism , Interleukin-4/metabolism , Macrophages/microbiology , Mice , Microscopy, Confocal , Phagosomes/immunology , Phagosomes/metabolism , Proto-Oncogene Proteins c-akt/immunology , Proto-Oncogene Proteins c-akt/metabolism , STAT6 Transcription Factor/immunology , STAT6 Transcription Factor/metabolism , Transfection
11.
Microbiology (Reading) ; 153(Pt 2): 529-540, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17259625

ABSTRACT

The eis gene of Mycobacterium tuberculosis has been shown to play a role in the survival of the avirulent Mycobacterium smegmatis within the macrophage. In vitro and in vivo analysis of Deltaeis deletion mutants and complemented strains showed no effect on survival of M. tuberculosis in U-937 macrophages or in a mouse aerosol infection model, respectively. Further studies were done in an attempt to determine the role of eis in M. tuberculosis intracellular survival and to define a phenotypic difference between wild-type and the Deltaeis deletion mutant. Bioinformatic analysis indicated that Eis is an acetyltransferase of the GCN5-related family of N-acetyltransferases. Immunofluorescence microscopy and Western blot analysis studies demonstrated that Eis is released into the cytoplasm of M. tuberculosis-infected U-937 macrophages. Eis was also found in the extravesicular fraction and culture supernatant of M. tuberculosis-infected macrophages. The effect of Eis on human macrophage cytokine secretion was also examined. Eis modulated the secretion of IL-10 and TNF-alpha by primary human monocytes in response both to infection with M. tuberculosis and to stimulation with recombinant Eis protein. These results suggest that Eis is a mycobacterial effector that is released into the host cell to modulate inflammatory responses, possibly via transcriptional or post-translational means.


Subject(s)
Antigens, Bacterial/metabolism , Bacterial Proteins/metabolism , Cytokines/metabolism , Cytoplasm/metabolism , Macrophages/microbiology , Mycobacterium tuberculosis/pathogenicity , Acetyltransferases/genetics , Acetyltransferases/metabolism , Animals , Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Computational Biology , Female , Humans , Macrophages/immunology , Macrophages/metabolism , Mice , Mice, Inbred C57BL , Monocytes/immunology , Monocytes/metabolism , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/growth & development , Mycobacterium tuberculosis/metabolism , U937 Cells , Virulence
12.
J Cell Biol ; 174(7): 923-9, 2006 Sep 25.
Article in English | MEDLINE | ID: mdl-16982798

ABSTRACT

Phagosomes offer kinetically and morphologically tractable organelles to dissect the control of phagolysosome biogenesis by Rab GTPases. Model phagosomes harboring latex beads undergo a coordinated Rab5-Rab7 exchange, which is akin to the process of endosomal Rab conversion, the control mechanisms of which are unknown. In the process of blocking phagosomal maturation, the intracellular pathogen Mycobacterium tuberculosis prevents Rab7 acquisition, thus, providing a naturally occurring tool to study Rab conversion. We show that M. tuberculosis inhibition of Rab7 acquisition and arrest of phagosomal maturation depends on Rab22a. Four-dimensional microscopy revealed that phagosomes harboring live mycobacteria recruited and retained increasing amounts of Rab22a. Rab22a knockdown in macrophages via siRNA enhanced the maturation of phagosomes with live mycobacteria. Conversely, overexpression of the GTP-locked mutant Rab22aQ64L prevented maturation of phagosomes containing heat-killed mycobacteria, which normally progress into phagolysosomes. Moreover, Rab22a knockdown led to Rab7 acquisition by phagosomes harboring live mycobacteria. Our findings show that Rab22a defines the critical checkpoint for Rab7 conversion on phagosomes, allowing or disallowing organellar transition into a late endosomal compartment. M. tuberculosis parasitizes this process by actively recruiting and maintaining Rab22a on its phagosome, thus, preventing Rab7 acquisition and blocking phagolysosomal biogenesis.


Subject(s)
Mycobacterium bovis/physiology , Phagosomes/physiology , rab GTP-Binding Proteins/physiology , Cells, Cultured , Genetic Vectors , Macrophages/cytology , Macrophages/metabolism , Macrophages/microbiology , Microscopy, Confocal , Mycobacterium bovis/genetics , Plasmids , rab GTP-Binding Proteins/genetics , rab7 GTP-Binding Proteins
13.
FEMS Microbiol Lett ; 243(1): 243-9, 2005 Feb 01.
Article in English | MEDLINE | ID: mdl-15668025

ABSTRACT

Reporter systems efficient at monitoring temporal gene expression in slow-growing mycobacteria would significantly aid the characterization of gene expression in specific environments. Bacterial luciferase is a reporter that has not been widely used to study gene expression in mycobacteria. This report describes the determination of the degradation of bacterial luciferase in Mycobacterium tuberculosis H37Ra and its utility as a reporter of temporal gene expression in this slow-growing mycobacterium. The inducible/repressible alanine dehydrogenase promoter of M. tuberculosis H37Rv was used to track the decay kinetics of Vibrio harveyi luciferase in both mid-log phase and stationary phase grown M. tuberculosis H37Ra, which proved to be highly similar during both phases of growth. The luciferase reporter was then used to detect changes in expression from the heat-shock promoter, phsp60, of M. bovis BCG during M. tuberculosis H37Ra growth in culture. Quantitative real-time PCR analysis of groEL2, the hsp60 homologue in M. tuberculosis, displayed a similar pattern of expression to phsp60-driven luciferase. These results strongly suggest that the luciferase reporter can be used to monitor temporal changes in gene expression in M. tuberculosis and may serve as a novel system to examine gene expression under specific conditions.


Subject(s)
Gene Expression Regulation, Bacterial , Genes, Reporter , Luciferases/metabolism , Mycobacterium tuberculosis/metabolism , Vibrio/enzymology , Alanine Dehydrogenase , Amino Acid Oxidoreductases/genetics , Amino Acid Oxidoreductases/metabolism , Chaperonin 60/genetics , Chaperonin 60/metabolism , Half-Life , Luciferases/genetics , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/growth & development , Vibrio/genetics
14.
J Bacteriol ; 186(16): 5410-7, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15292142

ABSTRACT

To further understand Mycobacterium tuberculosis pathogenesis, the regulation of potential virulence genes needs to be investigated. The eis gene of M. tuberculosis H37Rv enhances the intracellular survival of Mycobacterium smegmatis, which does not contain eis, within macrophages (J. Wei, J. L. Dahl, J. W. Moulder, E. A. Roberts, P. O'Gaora, D. B. Young, and R. L. Friedman, J. Bacteriol. 182:377-384, 2000). Experiments were done to characterize the eis promoter in M. smegmatis and M. tuberculosis H37Ra. The putative -10 and -35 regions matched the Escherichia coli sigma(70) consensus 67 and 83%, respectively, making it a group A/SigA-like mycobacterial promoter. Expression of site-directed variants of the core promoter region, determined by flow cytometry using gfp as a reporter, showed that the putative -10 region is essential for eis expression. In addition, site-directed alteration of the eis promoter to the consensus E. coli sigma(70) promoter elements increased gfp transcription to levels similar to that driven by the heat shock promoter, phsp60, of Mycobacterium bovis BCG. Upstream promoter deletion analysis showed that a 200- and 412-bp region of the promoter was necessary for maximum expression of gfp in M. smegmatis and M. tuberculosis H37Ra, respectively. Random mutagenesis of the 412-bp eis promoter, using a catechol 2,3-dioxygenase screen and activity assay, defined nucleotides upstream of the core promoter region that are essential to eis expression in both M. smegmatis and M. tuberculosis H37Ra, including a region homologous to a DinR cis element.


Subject(s)
Antigens, Bacterial/genetics , Bacterial Proteins/genetics , Dioxygenases , Mycobacterium tuberculosis/genetics , Promoter Regions, Genetic , Acetyltransferases , Adaptation, Physiological , Catechol 2,3-Dioxygenase , DNA Mutational Analysis , Gene Expression Regulation, Bacterial , Genes, Reporter , Green Fluorescent Proteins , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Macrophages/microbiology , Mutagenesis, Site-Directed , Mutation , Mycobacterium smegmatis/genetics , Mycobacterium tuberculosis/growth & development , Mycobacterium tuberculosis/pathogenicity , Oxygenases/genetics , Oxygenases/metabolism , Sequence Deletion , Transcription Initiation Site , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...